SPARCL1 (secreted protein acidic and cysteine-rich like 1), a member of the SPARC family, may act as a tumor suppressor in renal cell carcinoma, regulating disease progression through the p38/JNK/ERK pathway [49]. This evidence concerns the gene MAPK8 and renal cell carcinoma.